Lenalidomide in cancer cachexia: a randomized trial of an anticancer drug applied for anti‐cachexia

• Principais autores: David Blum (Autor), Caroline Hertler (Autor), Rolf Oberholzer (Autor), Susanne deWolf‐Linder (Autor), Markus Joerger (Autor), Christoph Driessen (Autor), Florian Strasser (Autor)
• Formato: Livro
• Publicado em: Wiley, 2022-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Cancer cachexia (CC) impacts quality of life, physical function, anticancer treatment response, and survival. Inflammation is a prominent pathomechanism of CC. This small‐scale study sets out to investigate the immunomodulatory drug lenalidomide in inflammatory CC in a randomized...